دورية أكاديمية

Clinical experience in the treatment of spinal cord tumors with cyberknife® fractionated stereotactic radiotherapy.

التفاصيل البيبلوغرافية
العنوان: Clinical experience in the treatment of spinal cord tumors with cyberknife® fractionated stereotactic radiotherapy.
المؤلفون: Avci, Gulhan Guler, Inan, Gonca Altinisik, Arslan, Suheyla Aytac, Guney, Yildiz, Breuneval, Mehtap Coskun
المصدر: Annals of Medical of Research; May2021, Vol. 28 Issue 5, p884-887, 4p
مصطلحات موضوعية: STEREOTACTIC radiotherapy, SPINAL cord tumors, HEMANGIOBLASTOMAS, STEREOTACTIC radiosurgery, CLINICAL trials
مستخلص: Aim: The aim of the study is to evaluate the effcacy and safety of Cyberknife® fractionated stereotactic radiotherapy (FSRT) in spinal cord tumors. The secondary aim is to present short-term local control of the patients with spinal cord tumors. Materials and Methods: Ten patients with spinal cord tumors who underwent FSRT between January 2010 and May 2014 were retrospectively analyzed. FSRT was administered in a median dose of 20 Gy (range, 16-40 Gy) in a median 5 fractions (range, 4-6 fractions). Radiological / pathological diagnoses of the patients are meningioma (n = 3), schwannoma (n = 1), neurofbroma (n = 1), hemangioblastoma (n = 1), chordoma (n = 1), recurrent medulloblastoma (n = 1), recurrent ependymoma (n = 2). Results: The median age was 57 years (range, 22-84 years). The median tumor volume was 3.3 cm3 (range, 1.8- 74 cm3 ). Tumor localization was cervical in six cases, lumbar in three cases, and thoracic in one case. The median follow-up time was 13 months (range, 3-48 months). Clinical improvement was observed by FSRT in all patients except the three cases. Tumor control (no progression) was achieved in all cases. Radiologically, 6 patients were stable, 2 patients had complete and 1 patient had a partial response. No acute toxicity due to FSRT was observed in any cases. Conclusion: Stereotactic radiosurgery /radiotherapy provides acceptable toxicity and excellent local control results in patients with spinal cord tumors. However, well-designed studies with longer follow-up and a large number of patients are warranted. [ABSTRACT FROM AUTHOR]
Copyright of Annals of Medical of Research is the property of Annals of Medical Research and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
قاعدة البيانات: Complementary Index
الوصف
تدمد:26367688
DOI:10.5455/annalsmedres.2020.05.446